Description
BSE notifies listing of 2000 bonus equity shares of Sun Pharmaceutical Industries Ltd. that were kept in abeyance, with trading commencing from January 12, 2026.
Summary
BSE has announced the listing of 2000 bonus equity shares of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) that were previously kept in abeyance. These shares will be listed and permitted to trade with effect from Monday, January 12, 2026. The shares have a face value of Rs. 1/- each and are allocated across two distinctive number ranges.
Key Points
- 2000 bonus equity shares of Rs. 1/- each are being listed
- Scrip Code: 524715
- ISIN: INE044A01036
- Trading commences from January 12, 2026
- Shares distributed in two blocks: 1000 shares each with distinctive numbers 1035573706-1035574705 and 1042698157-1042699156
- These shares were previously kept in abeyance
Regulatory Changes
No regulatory changes. This is a standard listing notification for shares that were previously held in abeyance.
Compliance Requirements
Trading members of BSE are informed about the listing and should update their systems to reflect the availability of these shares for trading from January 12, 2026.
Important Dates
- Notice Date: January 9, 2026
- Trading Commencement Date: January 12, 2026
Impact Assessment
The impact is minimal as only 2000 bonus shares are being released from abeyance for Sun Pharmaceutical Industries Ltd. This represents a negligible addition to the existing float and is unlikely to have any material effect on the stock’s trading or market capitalization. This is a routine administrative action to resolve previously held-in-abeyance bonus shares.
Impact Justification
Relates to a small number of bonus shares (2000) kept in abeyance for a single company, minimal market impact